MARK 

 

DE SOUZA 

EXECUTIVE OFFICER, DIRECTOR

PELLEPHARM, INC.   |  MYOTHERIX, INC.   |  NFLECTION THERAPEUTICS, INC.   |  FIBRX DERM, INC.   |  RNADERM THERAPEUTICS, INC.   |  REILLY-S HEMP, INC.   |  ICC HOLDINGS, LLC   |  SEYLANMED LLC   |  FLIGHTPATH BIOSCIENCES, INC.   |  KAMAL THERAPEUTICS, INC.

MARK 

P. 

DE SOUZA 

DIRECTOR

CHROMADERM, INC.   |  WILLOW NEUROSCIENCE, INC.   |  WINGS THERAPEUTICS, INC.   |  FLIGHTPATH BIOSCIENCES, INC.   |  SONALASENSE, INC.   |  PHOENICIS THERAPEUTICS, INC.

HAL 

 

LANDY 

DIRECTOR

WINGS THERAPEUTICS, INC.   |  PHOENICIS THERAPEUTICS, INC.

JOFF 

 

MASUKAWA 

DIRECTOR

PHOENICIS THERAPEUTICS, INC.

JOHN 

 

PARKER 

DIRECTOR

QUALITY SERVICE CERTIFICATION INC   |  SOLICORE INC   |  BENTALL KENNEDY (U.S.) G.P. LLC   |  INTERMOUNTAIN COMMUNITY BANCORP   |  RC-1, INC.   |  SPRINGHOOD CHILD HEALTH VENTURES FUND I, L.P.   |  LONGEVITI NEURO SOLUTIONS, LLC   |  KAMAL THERAPEUTICS, INC.

DEBORAH 

 

RAMSDELL 

EXECUTIVE OFFICER, DIRECTOR

PHOENICIS THERAPEUTICS, INC.

PHILIP 

 

REILLY 

DIRECTOR

PLATELET BIOGENESIS, INC.   |  LUNA GENETICS, INC.   |  KAMAL THERAPEUTICS, INC.

ALEXANDER 

 

SILVER 

DIRECTOR

PHOENICIS THERAPEUTICS, INC.   |  ANANYM CAPITAL ONSHORE FUND, LP   |  ANANYM CAPITAL LONG-ONLY ONSHORE FUND, LP